Artemis Therapeutics Inc. has no significant operations. Previously, he was engaged in the development of agents for the prevention and treatment of serious and life-threatening infectious diseases. The company is headquartered in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd. How to buy Artemis Therapeutics (ATMS) shares, Tutorial explained Do … Leer más
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. The company develops autologous tumor-infiltrating lymphocyte (TIL) cell therapy. Its TIL product candidates in development include ITIL-168 for indications including melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 … Leer más
Oncorus, Inc., a clinical-stage biopharmaceutical company, is focused on the development of viral immunotherapies for cancer patients. The company’s lead product candidate is ONCR-177, an intratumorally delivered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for the treatment of various cancers. It is also … Leer más
JW (Cayman) Therapeutics Co. Ltd, a clinical-stage cell therapy company, focuses on developing, manufacturing and marketing cell-based immunotherapies for hematologic cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T therapies, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is relmacabtagene autoleucel, an anti-CD19 CAR-T … Leer más
Oxford Biodynamics PLC, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industries primarily in the United States and internationally. The company provides Episwitch with a proprietary technology platform for the discovery, evaluation, validation and monitoring of epigenetic biomarkers known as chromosome conformation signatures. It has collaboration agreements with the … Leer más
Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Its lead product candidate is BMF-219, an orally bioavailable, potent and selective irreversible inhibitor of MENIN, a transcriptional regulator of oncogenic signaling in multiple cancers. The company was founded in … Leer más
Medis Pharma SA, a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. Its products include nanolithium (NP03), a clinical-stage development product for the treatment of Alzheimer’s disease; NANOSIRNA DH for the treatment of Huntington’s disease; NU01 Plutonium and Cesium decoration products NU02 for … Leer más
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, is engaged in the research, development and commercialization of therapies that address unmet medical needs in the People’s Republic of China. It is developing several drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, … Leer más
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, is focused on developing therapeutics for patients with rare genetic mitochondrial diseases. Develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in a phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as a phase 1b clinical trial in patients with fatty acid … Leer más
MedMira Inc., a biotechnology company, researches, develops, manufactures and markets rapid diagnostic and technology platforms in North America, Latin America, the Caribbean, Europe and Asia Pacific. The company’s research focuses on specific areas of the diagnostics market, such as the rapid, point-of-care and in vitro sectors. Offers Reveal HIV, which detects HIV-1 and HIV-2 antibodies … Leer más